Corbus Pharmaceuticals Holdings (CRBP) Profit After Tax (2013 - 2025)

Corbus Pharmaceuticals Holdings' Profit After Tax history runs 13 years deep, the most recent figure standing at -$23.3 million for Q3 2025.

• In Q3 2025, Profit After Tax fell 69.35% year-over-year to -$23.3 million; the TTM figure through Sep 2025 stood at -$67.6 million (down 74.59% YoY), while the FY2024 annual figure was -$40.2 million, up 9.85% from the prior year.
• Profit After Tax for Q3 2025 stood at -$23.3 million, down from -$17.7 million in the prior quarter.
• The five-year high for Profit After Tax was -$2.2 million in Q3 2021, with the low at -$23.3 million in Q3 2025.
• The 5-year median for Profit After Tax is -$10.3 million (2021), against an average of -$12.2 million.
• The sharpest annual moves came in 2021 and 2022: Profit After Tax surged 93.76% in 2021, then plunged 307.57% in 2022.
• Corbus Pharmaceuticals Holdings' Profit After Tax stood at -$10.3 million in 2021, then fell by 5.24% to -$10.8 million in 2022, then increased by 25.71% to -$8.0 million in 2023, then decreased by 18.8% to -$9.5 million in 2024, then plunged by 144.93% to -$23.3 million in 2025.
• Business Quant data shows CRBP's Profit After Tax at -$23.3 million in Q3 2025, -$17.7 million in Q2 2025, and -$17.0 million in Q1 2025.